Hypercytokinemia and Pathogen–Host Interaction in COVID-19
Alaa Badawi1,2 1Public Health Risk Sciences Division, Public Health Agency of Canada, Toronto, ON, Canada; 2Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, ON, CanadaCorrespondence: Alaa BadawiPublic Health Risk Sciences Division, Public Health Agency of Cana...
Guardado en:
Autor principal: | Badawi A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5fcb65971ea44aea9c16fbc9cf48384c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alterations in the Plasma Proteome Induced by SARS-CoV-2 and MERS-CoV Reveal Biomarkers for Disease Outcomes for COVID-19 Patients
por: Alaiya A, et al.
Publicado: (2021) -
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang XY, et al.
Publicado: (2021) -
Neopterin: A Promising Candidate Biomarker for Severe COVID-19
por: Hailemichael W, et al.
Publicado: (2021) -
Distinct Patterns of Blood Cytokines Beyond a Cytokine Storm Predict Mortality in COVID-19
por: Herr C, et al.
Publicado: (2021) -
Dynamic Changes of Antibodies to SARS-CoV-2 in Close Contacts
por: Yao J, et al.
Publicado: (2021)